CAS 2449301-27-1

Fórmula: C17H12FN3

InChI: InChI=1S/C17H12FN3/c18-13-3-1-2-11(8-13)4-5-12-6-7-14-15(10-19)17(20)21-16(14)9-12/h1-9,21H,20H2/b5-4+

Chave InChI: CGXBPMZRTMXEIA-SNAWJCMRSA-N

SMILES: C1=CC(=CC(=C1)F)/C=C/C2=CC3=C(C=C2)C(=C(N3)N)C#N

GSK2643943A

CAS: 2449301-27-1

GSK2643943A

Fórmula: C₁₇H₁₂FN₃

Pureza: ≥95%

Peso molecular: 277.3

Ref: 54-BUP05269

2-Amino-6-(3-fluorostyryl)-1H-indole-3-carbonitrile

CAS: 2449301-27-1

Fórmula: C₁₇H₁₂FN₃

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 277.2957

Ref: IN-DA01V4YB

GSK2643943A

CAS: 2449301-27-1

2-Amino-6-(3-fluorostyryl)-1H-indole-3-carbonitrile

Fórmula: C₁₇H₁₂FN₃

Pureza: 98%

Peso molecular: 277.3

Ref: IN-DG01293411

GSK2643943A

CAS: 2449301-27-1

GSK2643943A is an investigational drug, which is a product of GlaxoSmithKline's extensive research efforts. It is a small molecule inhibitor targeting specific cellular pathways involved in tumor growth and proliferation. This compound is designed to selectively inhibit kinase signaling, a process critical for the survival and metastasis of cancer cells. By disrupting these pathways, GSK2643943A aims to impede cancer progression, offering a potential new avenue for therapeutic intervention in oncology.

Fórmula: C₁₇H₁₂FN₃

Pureza: Min. 95%

Peso molecular: 277.29 g/mol

Ref: 3D-ZXD30127

GSK2643943A

CAS: 2449301-27-1

GSK2643943A is a deubiquitylating enzyme (DUB) inhibitor, with an IC 50 of 160 nM for USP20/Ub-Rho. GSK2643943A has anti-tumor efficacy.

Fórmula: C₁₇H₁₂FN₃

Pureza: 97.09%

Cor e Forma: Solid

Peso molecular: 277.2957

Ref: TM-T11485